financetom
Business
financetom
/
Business
/
Damon Names Dominique Kwong as Interim CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Damon Names Dominique Kwong as Interim CEO
Dec 5, 2024 9:57 AM

12:25 PM EST, 12/05/2024 (MT Newswires) -- Damon (DMN) said Thursday it has appointed Damon cofounder Dominique Kwong as interim chief executive officer, succeeding Jay Giraud.

Kwong previously served as chief technology officer and subsequently as chief operating officer of the company.

The motorcycle manufacturer gave no reason for the management shakeup, which also involves independent director Shashi Tripathi becoming chairman of the board. Tripathi is currently the CEO of Sleepiz USA.

Shares of the company were down nearly 11% in recent trading.

Price: 0.92, Change: -0.11, Percent Change: -10.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TE Connectivity to acquire Richards Manufacturing for about $2.3 billion
TE Connectivity to acquire Richards Manufacturing for about $2.3 billion
Feb 12, 2025
Feb 12 (Reuters) - TE Connectivity ( TEL ) said on Wednesday it would buy Richards Manufacturing Co from funds managed by Oaktree Capital Management and members of the Bier family for about $2.3 billion in cash, aiming to expand in the energy market. ...
NiSource Q4 Adjusted Earnings Fall; Raises 2025 Adjusted Earnings Guidance
NiSource Q4 Adjusted Earnings Fall; Raises 2025 Adjusted Earnings Guidance
Feb 12, 2025
06:54 AM EST, 02/12/2025 (MT Newswires) -- NiSource ( NI ) reported Q4 adjusted earnings Wednesday of $0.49 per diluted share, down from $0.53 a year earlier. Analysts polled by FactSet expected $0.48. The company raised its 2025 adjusted EPS guidance to $1.85 to $1.89 from $1.84 to $1.88. Analysts surveyed by FactSet expect $1.86. ...
CVS Health Q4 Adjusted Earnings Decline, Revenue Increases; 2025 Adjusted EPS Outlook Issued
CVS Health Q4 Adjusted Earnings Decline, Revenue Increases; 2025 Adjusted EPS Outlook Issued
Feb 12, 2025
06:48 AM EST, 02/12/2025 (MT Newswires) -- CVS Health ( CVS ) reported Q4 adjusted earnings Wednesday of $1.19 per diluted share, down from $2.12 a year earlier. Analysts polled by FactSet expected $0.91. Revenue for the quarter ended Dec. 31 was $97.71 billion, up from $93.81 billion a year earlier. Analysts surveyed by FactSet expected $97.09 billion. For 2025,...
Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
Feb 12, 2025
(Reuters) -Biogen forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hurt by a strong dollar and fierce competition for its drugs to treat multiple sclerosis. Its shares fell 3.7% in premarket trading after losing more than 40% of their value last year. The company had a market capitalization of about $20 billion as of its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved